Cargando…

Neurofeedback Treatment on Depressive Symptoms and Functional Recovery in Treatment-Resistant Patients with Major Depressive Disorder: an Open-Label Pilot Study

BACKGROUND: We evaluated the effects of neurofeedback as an augmentation treatment on depressive symptoms and functional recovery in patients with treatment-resistant depression (TRD). METHODS: We included 24 adult patients with TRD and 12 healthy adults. 24 TRD patients were assigned to the neurofe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Young-Ji, Lee, Ga-Won, Seo, Wan-Seok, Koo, Bon-Hoon, Kim, Hye-Geum, Cheon, Eun-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823520/ https://www.ncbi.nlm.nih.gov/pubmed/31674161 http://dx.doi.org/10.3346/jkms.2019.34.e287

Ejemplares similares

Management of Panic Disorder with Neurofeedback in Patients with Muscular Dystrophy: A Case Report
por: Kim, Hye-Geum, et al.
Publicado: (2021)

PT569. Association between cerebral amyloid deposition and cognitive function in geriatric depression: pilot study using amyloid PET
por: Kim, Hye-Geum, et al.
Publicado: (2016)

Neurofeedback As a Treatment for Major Depressive Disorder – A Pilot Study
por: Peeters, Frenk, et al.
Publicado: (2014)

Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression
por: Kim, Hye-Geum, et al.
Publicado: (2019)

Duloxetine in the treatment of major depressive disorder: an open-label study
por: Hudson, James I, et al.
Publicado: (2007)

Association between Cerebral Amyloid Deposition and Clinical Factors Including Cognitive Function in Geriatric Depression: Pilot Study Using Amyloid Positron Emission Tomography
por: Kim, Hye-Geum, et al.
Publicado: (2016)

Neurofeedback and networks of depression
por: Linden, David E. J.
Publicado: (2014)

Effects of neurofeedback on major depressive disorder: a systematic review
por: Dobbins, Isabelly Cristine de Souza, et al.
Publicado: (2023)

Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
por: Cheon, Eun-Jin, et al.
Publicado: (2016)

Psychiatric understanding and treatment of patients with amputations
por: Jo, So-Hye, et al.
Publicado: (2021)

The Effects of QEEG-Informed Neurofeedback in ADHD: An Open-Label Pilot Study
por: Arns, Martijn, et al.
Publicado: (2012)

A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises
por: Pae, Chi-Un, et al.
Publicado: (2014)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Maintenance use of ketamine for treatment-resistant depression: an open-label pilot study
por: Barenboim, Ivan, et al.
Publicado: (2018)

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
por: Otsubo, Tempei, et al.
Publicado: (2018)

Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study
por: Song, Hoo Rim, et al.
Publicado: (2015)

Musical neurofeedback for treating depression in elderly people
por: Ramirez, Rafael, et al.
Publicado: (2015)

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]
Publicado: (2013)

Clinical Significance of the Number of Depressive Symptoms in Major Depressive Disorder: Results from the CRESCEND Study
por: Park, Seon-Cheol, et al.
Publicado: (2016)

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
por: Wohlreich, Madelaine M, et al.
Publicado: (2004)

A controlled study on the cognitive effect of alpha neurofeedback training in patients with major depressive disorder
por: Escolano, Carlos, et al.
Publicado: (2014)

Real-Time fMRI Neurofeedback Training of Amygdala Activity in Patients with Major Depressive Disorder
por: Young, Kymberly D., et al.
Publicado: (2014)

Efficacy of bio- and neurofeedback for depression: a meta-analysis
por: Fernández-Alvarez, J., et al.
Publicado: (2022)

Neurofeedback and Affect Regulation Circuitry in Depressed and Healthy Adolescents
por: Nguyen, Giang H., et al.
Publicado: (2023)

Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study
por: Santos García, Diego, et al.
Publicado: (2022)

Combining intensive repetitive transcranial magnetic stimulation with neurofeedback in a case of treatment-resistant depression
por: Bruno, Antonio, et al.
Publicado: (2021)

Review of EEG-based neurofeedback as a therapeutic intervention to treat depression
por: Patil, Abhishek Uday, et al.
Publicado: (2023)

Blame-rebalance fMRI neurofeedback in major depressive disorder: A randomised proof-of-concept trial
por: Zahn, Roland, et al.
Publicado: (2019)

Self-blame in major depression: a randomised pilot trial comparing fMRI neurofeedback with self-guided psychological strategies
por: Jaeckle, Tanja, et al.
Publicado: (2023)

Transdermal selegiline for the treatment of major depressive disorder
por: Lee, Kelly C, et al.
Publicado: (2007)

The psychological impact of the coronavirus disease pandemic on hospital workers in Daegu, South Korea
por: Jo, So-Hye, et al.
Publicado: (2020)

Open‐label, proof‐of‐concept study of brexanolone in the treatment of severe postpartum depression
por: Kanes, Stephen J., et al.
Publicado: (2017)

An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
por: Kumar, Pattath Narayanan Suresh, et al.
Publicado: (2022)

Neurofeedback training improves anxiety trait and depressive symptom in GAD
por: Hou, Yue, et al.
Publicado: (2021)

Real-time fMRI neurofeedback compared to cognitive behavioral therapy in a pilot study for the treatment of mild and moderate depression
por: Mel’nikov, Mikhail Ye., et al.
Publicado: (2022)

Stress and Heart Rate Variability: A Meta-Analysis and Review of the Literature
por: Kim, Hye-Geum, et al.
Publicado: (2018)

Transient effects of multi‐infusion ketamine augmentation on treatment‐resistant depressive symptoms in patients with treatment‐resistant bipolar depression – An open‐label three‐week pilot study
por: Zhuo, Chuanjun, et al.
Publicado: (2020)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
por: Oluboka, Oloruntoba J, et al.
Publicado: (2017)

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
por: Donegan, Carina Joy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mndqsq7tgngi51q4qdn6g821m1